JPMorgan Upgrades Baidu: Cloud and AI to Drive Growth
JPMorgan upgrades Baidu to Overweight, citing strong growth potential in cloud and AI, with a new price target of $188.
Already have an account? Sign in.
JPMorgan upgrades Baidu to Overweight, citing strong growth potential in cloud and AI, with a new price target of $188.
Merck’s tulisokibart met its Phase 2b HS goal and will move to Phase 3. H.C. Wainwright sees first anti-TL1A skin data as a class plus for Shattuck.
FERC paused PJM’s backup capacity auction after calling the last-minute filing a mess. Cost-sharing fights and stock drops follow.
A Delaware judge found Liquidia’s Yutrepia infringes United Therapeutics’ PH-ILD patent. Final judgment is next.